This study introduced patients with HCC post TACE to an internet-based mindfulness-based interventions and sought their perceptions of the experience.

Researchers conducted a prospective, observational study to explore the impact of nutritional status prior to cancer treatment initiation and mortality risk.

The approval was based on the AMPLIFY trial, which evaluated acalabrutinib alongside venetoclax in adults with previously untreated CLL without del(17p) or TP53 mutation.

Whole-pelvis RT linked to improved PFS for patients with prostate cancer staged TrN0M0, while ADT linked to improved PFS in patients staged N1/M1.

The RFC1 G80A polymorphism is closely associated with higher rates of methotrexate-induced toxicity in pediatric acute lymphoblastic leukemia (ALL), according to a study published in the World Journal ...

In this study, researchers aimed to examine trends in nonsurgical management and other treatment modalities in low-risk, HR-positive DCIS.

Researchers conducted a literature review to better understand challenges faced by LGB patients with CRC after surgical treatment of their disease.

Researchers sought to determine whether adding nivolumab to R-CHOP would be safe and effective in the previously untreated DLBCL setting.

In this retrospective analysis, researchers studied adult patients who were diagnosed with non-metastatic breast cancer and received GLP1-RAs for at least 3 months.

MDT associated with improved progression-free, radiographic progression-free, castration resistance-free survival.

A retrospective study sought to confirm real-world outcomes of patients with HER2+ breast cancer treated with trastuzumab deruxtecan.

Prehabilitation improves outcomes for patients undergoing surgical treatment for cancer, but this study explored its benefits for those undergoing nonsurgical treatments.